Literature DB >> 28774757

Editorial Commentary: Clinical management of cardiovascular disease in HIV-infected patients.

Alison Kearns1, Tricia H Burdo1, Xuebin Qin2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28774757      PMCID： PMC5978434          DOI： 10.1016/j.tcm.2017.07.007

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN： 1050-1738            Impact factor:   6.677


× No keyword cloud information.
  13 in total

1.  Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection.

Authors:  John A Ambrose; Randy B Gould; Damian C Kurian; Mary C DeVoe; Nicole B Pearlstein; John T Coppola; Frederick P Siegal
Journal:  Am J Cardiol       Date:  2003-08-01       Impact factor: 2.778

2.  Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

Authors:  Janet Lo; Suhny Abbara; Leon Shturman; Anand Soni; Jeffrey Wei; Jose A Rocha-Filho; Khurram Nasir; Steven K Grinspoon
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

3.  Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients.

Authors:  Tricia H Burdo; Janet Lo; Suhny Abbara; Jeffrey Wei; Michelle E DeLelys; Fred Preffer; Eric S Rosenberg; Kenneth C Williams; Steven Grinspoon
Journal:  J Infect Dis       Date:  2011-10-15       Impact factor: 5.226

4.  HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial.

Authors:  Jennifer M Gilbert; Kathleen V Fitch; Steven K Grinspoon
Journal:  Top Antivir Med       Date:  2015 Oct-Nov

5.  CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment.

Authors:  Judith S Currier; Diane V Havlir
Journal:  Top Antivir Med       Date:  2017 May/Jun

6.  The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans.

Authors:  Kristina Crothers; Tephany A Griffith; Kathleen A McGinnis; Maria C Rodriguez-Barradas; David A Leaf; Sharon Weissman; Cynthia L Gibert; Adeel A Butt; Amy C Justice
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

Review 7.  HIV-1-Associated Atherosclerosis: Unraveling the Missing Link.

Authors:  Alison Kearns; Jennifer Gordon; Tricia H Burdo; Xuebin Qin
Journal:  J Am Coll Cardiol       Date:  2017-06-27       Impact factor: 24.094

8.  Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

Authors:  Nina Friis-Møller; Rainer Weber; Peter Reiss; Rodolphe Thiébaut; Ole Kirk; Antonella d'Arminio Monforte; Christian Pradier; Linda Morfeldt; Silvia Mateu; Matthew Law; Wafaa El-Sadr; Stephan De Wit; Caroline A Sabin; Andrew N Phillips; Jens D Lundgren
Journal:  AIDS       Date:  2003-05-23       Impact factor: 4.177

9.  Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States.

Authors:  Elena Losina; Emily P Hyle; Ethan D Borre; Benjamin P Linas; Paul E Sax; Milton C Weinstein; Corinna Rusu; Andrea L Ciaranello; Rochelle P Walensky; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2017-10-15       Impact factor: 20.999

10.  Utility of 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines in HIV-Infected Adults With Carotid Atherosclerosis.

Authors:  Binh An P Phan; Bernard Weigel; Yifei Ma; Rebecca Scherzer; Danny Li; Sophia Hur; S C Kalapus; Steven Deeks; Priscilla Hsue
Journal:  Circ Cardiovasc Imaging       Date:  2017-07       Impact factor: 7.792
View more
  2 in total

1.  Elevated indoleamine-2,3-dioxygenase enzyme activity in a novel mouse model of HIV-associated atherosclerosis.

Authors:  Alison C Kearns; Stephani Velasquez; Fengming Liu; Shen Dai; Yong Chen; Gabrielle Lehmicke; Jennifer Gordon; Jay Rappaport; Xuebin Qin
Journal:  AIDS       Date:  2019-08-01       Impact factor: 4.177

2.  Caspase-1-associated immune activation in an accelerated SIV-infected rhesus macaque model.

Authors:  Alison C Kearns; Jake A Robinson; Masoud Shekarabi; Fengming Liu; Xuebin Qin; Tricia H Burdo
Journal:  J Neurovirol       Date:  2018-04-02       Impact factor: 2.643
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.